Anti-TNF alpha [CDP 571 (Humicade)]
Ab00448-1.1
ApplicationsELISA, Neutralisation/Blocking
Product group Antibodies
TargetTNF
Overview
- SupplierAbsolute Antibody
- Product NameAnti-TNF alpha [CDP 571 (Humicade)]
- Delivery Days Customer7
- Application Supplier NoteThe antibody binds specifically to TNF-alpha, a pro-inflammatory cytokine which stimulates release of other cytiokines e.g. IL-1, IL-6 and GM-CSF as well as secretion of ICAM-1 and VCAM-1 from endothelial cells. It stimulates acute phase responses and acts as a chemoattractant for NK cells and monocytes/macrophages. The antibody reached Phase II clinical trials with Celltech, UCB.
- ApplicationsELISA, Neutralisation/Blocking
- Applications SupplierELISA; NTRL
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDCDP 571 (Humicade)
- Gene ID7124
- Target nameTNF
- Target descriptiontumor necrosis factor
- Target synonymsDIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F, tumor necrosis factor, APC1 protein, TNF, macrophage-derived, TNF, monocyte-derived, TNF-a, tumor necrosis factor ligand 1F, tumor necrosis factor ligand superfamily member 2, tumor necrosis factor-alpha, tumor necrotic factor alpha
- HostMouse
- IsotypeIgG1
- Protein IDP01375
- Protein NameTumor necrosis factor
- Scientific DescriptionNOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC41116161



